Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Thursday 14 May 2020 3:39 pm

Coronavirus: What is the antibody test and how does it work?

By: James Warrington

Add as a preferred source on Google
ITALY-HEALTH-VIRUS

The prime minister’s official spokesperson today hailed an “important breakthrough” after the UK approved a Covid-19 antibody test.

The test has been tipped as a potential tool for helping the UK to ease the coronavirus lockdown.

But what is an antibody test, how does it work and why do we need one?

What is an antibody test?

Antibody tests — also known as serology tests — are used to determine whether someone has been infected with Covid-19.

By detecting antibodies used to fight coronavirus in the blood, it can show that a person has had the virus at some point in the past.

This may give some indication about immunity, although it is not yet clear whether the presence of antibodies means the person is permanently immune.

Until today, officials had not yet identified a test that was considered reliable.

However, an antibody test made by Swiss manufacturer Roche has now been granted regulatory approval.

Health minister Ed Argar this morning said the government will be ordering the first batch “as quickly as we can”.

How does the antibody test work?

The antibody test uses a small device that takes a blood sample through a finger prick. This needs to be done at least 14 days after symptoms develop and must be carried out by a healthcare professional.

The sample is then sent to be analysed on Roche’s cobas e analysers, which are widely used in NHS laboratories.

The automated tests can be carried out in 18 minutes and the machines can carry out up to 300 tests per hour.

Public Health England (PHE) has carried out testing on Roche’s antibody test at its Porton Down facility.

These showed the test are 100 per cent accurate when someone has been infected. If someone has not caught the virus, the test gives the correct result 99.8 per cent of the time.

Read more

Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

Why do we need these tests?

Prime Minister Boris Johnson has described the antibody test as a “game changer” and has been slated as a key tool for helping Britain get back to work.

Scientists believe people with coronavirus antibodies may develop immunity to Covid-19, allowing them to return to work safely. However, this is yet to be confirmed.

As well as being highly accurate, the antibody test provides more information than the current swab test, which only shows whether someone has the virus, not if they have previously had it and recovered.

Results from the antibody test are also returned much more quickly.

This means the government can use the test to determine what proportion of the population has been infected and track the spread of the virus across the country.

As well as helping officials to establish the prevalence of the disease, it could also allow lockdown measures to be determined locally.

In theory, the antibody test could also open the door to so-called immunity passports that would allow people who have already been infected to return to normal life.

However, scientists do not yet know enough about coronavirus immunity for this to be a viable option.

Can anyone get a test?

The Roche antibody test is not a rapid finger-prick test that can be used at home.

In March the government ordered 3.5m of these tests from manufacturers in China, but an Oxford University trial found they were insufficiently accurate.

Instead, the antibody test must be carried out by healthcare professionals and analysed in laboratories.

The government has not yet bought any tests — it is still in discussions with Roche about acquiring them.

Health minister Ed Argar today said the tests would first be distributed to frontline workers in the NHS and social care before extending testing more widely.

Read more

Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

Hikma produces generic drugs

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Politics

Related Topics

  • Coronavirus

Trending Articles

  • James Watt offers to buy back Brewdog

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • Motsepe backed to succeed Fifa’s Infantino by South African minister

  • Brewdog owner shrugs off James Watt takeover bid

  • Finsbury lines up Games Workshop splurge using merger windfall

More from City PM

  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

    Business Wire
  • Mahmood unveils refugee sponsorship route as asylum bill faces Labour test

    Politics
  • Private credit firms draft in City advisers to help with ‘meltdown’ stress test

    Banking
    Bank of England headquarters with financial charts overlay, illustrating private credit stress test analysis
  • Government sets out conditions for unlocking ‘trapped capital’ in defined benefit pension schemes

    Personal Finance
    Dominic Cummings claims China has stolen vast amounts of secret UK material
  • The seven growth tests every Budget must pass

    Opinion
    Chancellor holding iconic red budget box outside Downing Street, symbolizing UKs annual budget announcement
  • Kia Oval worth £80m to the UK economy as Test gets underway

    Sport Business
    Cityscape at dusk showcasing skyline with prominent skyscrapers under a vibrant sky, ideal for business news context.

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook